Usda approves merck animal health's nobivac® nxt canine flu h3n2 – the first and only rna-particle technology vaccine for canine influenza

Rahway, n.j.--(business wire)--merck animal health, known as msd animal health outside of the united states and canada, a division of merck & co., inc., rahway, n.j., usa (nyse:mrk), announced today the u.s. department of agriculture (usda) approval of nobivac® nxt canine flu h3n2, a next-level solution to help safeguard dogs against the ongoing threat of canine influenza. the product is expected to be available at veterinary clinics and hospitals nationwide late this summer. merck animal h.
NXT Ratings Summary
NXT Quant Ranking